Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
902.17B
Market cap902.17B
Price-Earnings ratio
40.08
Price-Earnings ratio40.08
Dividend yield
0.68%
Dividend yield0.68%
Average volume
2.96M
Average volume2.96M
High today
$976.68
High today$976.68
Low today
$919.00
Low today$919.00
Open price
$925.99
Open price$925.99
Volume
6.17M
Volume6.17M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 902.17B, Eli Lilly(LLY) trades at $955.85. The stock has a price-to-earnings ratio of 40.08 and currently yields dividends of 67.7%.

During the trading session on 2026-04-01, Eli Lilly(LLY) shares reached a daily high of $976.68 and a low of $919.00. At a current price of $955.85, the stock is +4.0% higher than the low and still -2.1% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 6.17M, versus its average volume of 2.96M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

LLY News

TipRanks 40m
Eli Lilly price target raised to $1,294 from $1,293 at BofA

BofA analyst Jason Gerberry raised the firm’s price target on Eli Lilly (LLY) to $1,294 from $1,293 and keeps a Buy rating on the shares. Following Foundayo’s U...

Seeking Alpha 2h
Lilly CEO says new GLP-1 pill's scalability will help expand global reach

Eli Lilly (LLY) CEO Dave Ricks said the company's newly approved GLP-1 pill, Foundayo, will help expand Lilly's reach in the global weight-loss market in part b...

Lilly CEO says new GLP-1 pill's scalability will help expand global reach
Benzinga 3h
What's Going On With Structure Therapeutics Stock On Wednesday?

• What’s the outlook for GCPR shares? FDA Approves Eli Lilly's Oral Weight Loss On Wednesday, the FDA approved Eli Lilly and Co.’s (NYSE:LLY) Foundayo (orforg...

What's Going On With Structure Therapeutics Stock On Wednesday?

Analyst ratings

83%

of 35 ratings
Buy
82.9%
Hold
14.3%
Sell
2.9%

More LLY News

TipRanks 3h
CEO says Lilly against push to pass drug pricing deals into law, CNBC reports

Eli Lilly (LLY) opposes the White House’s push to codify “most favored nation” drug pricing into law, CEO Dave Ricks said in an interview with CNBC. Lilly is on...

The Motley Fool 3h
Could This New Approval Be a Turning Point For Novo Nordisk?

Novo Nordisk (NVO 0.95%) was the leader in the weight-loss market several years ago, with the company's now-famous anti-obesity medicine, Wegovy, flying off the...

Could This New Approval Be a Turning Point For Novo Nordisk?
CNBC 3h
Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says

Key Points Eli Lilly opposes the White House's push to codify 'Most Favored Nations' drug pricing, Lilly CEO Dave Ricks said in an interview with CNBC. Lilly i...

Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says
Benzinga 4h
Why Is Eli Lilly Stock Gaining Today?

In the ATTAIN-1 trial, adults on the highest dose lost an average of 27 pounds, or 12.4% of body weight. The once-daily pill will be available via LillyDirect a...

Why Is Eli Lilly Stock Gaining Today?
TipRanks 4h
Eli Lilly Stock Surges as FDA Approves Weight-Loss Pill

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s (LLY) weight-loss pill for commercial sales, sending the company’s stock up 4% in midday tr...

Investor's Business Daily 5h
Eli Lilly Jumps After Winning FDA Approval For Obesity Pill

Eli Lilly To Buy Centessa Pharma For Up To $7.8 Billion; Centessa Shares Skyrocket 3/31/2026 Eli Lilly said Tuesday it would buy sleep-wake disorders drugmaker...

Eli Lilly Jumps After Winning FDA Approval For Obesity Pill
Bloomberg 5h
Lilly’s Obesity Pill Gets US Approval in Challenge to Novo

Eli Lilly & Co.’s weight-loss pill won US approval, ratcheting up pressure on Novo Nordisk A/S, which launched an obesity pill earlier this year. Lilly’s once...

Lilly’s Obesity Pill Gets US Approval in Challenge to Novo

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.